MOH Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory, IPB, CAMS-Fondation Mérieux, Institute of Pathogen Biology (IPB), Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Beijing, People's Republic of China.
Department of Microbiology and Immunology, College of Medicine, University of Illinois, Chicago, Illinois, USA
J Virol. 2014 Jun;88(12):6650-9. doi: 10.1128/JVI.03138-13. Epub 2014 Mar 26.
Human enterovirus 68 (EV68) is a member of the EV-D species, which belongs to the EV genus of the Picornaviridae family. Over the past several years, there have been increasingly documented outbreaks of respiratory disease associated with EV68. As a globally emerging pathogen, EV68 infects both adults and children. However, the molecular basis of EV68 pathogenesis is unknown. Here we report that EV68 inhibits Toll-like receptor 3 (TLR3)-mediated innate immune responses by targeting the TIR domain-containing adaptor inducing beta interferon (TRIF). In infected HeLa cells, EV68 inhibits poly(I·C)-induced interferon regulatory factor 3 (IRF3) activation and beta interferon (IFN-β) expression. Further investigations revealed that TRIF, a critical adaptor downstream of TLR3, is targeted by EV68. When expressed alone, 3C(pro), an EV68-encoded protease, cleaves TRIF. 3C(pro) mediates TRIF cleavage at Q312 and Q653, which are sites in the amino- and carboxyl-terminal domains, respectively. This cleavage relies on 3C(pro)'s cysteine protease activity. Cleavage of TRIF abolishes the capacity of TRIF to activate NF-κB and IFN-β signaling. These results suggest that control of TRIF by 3C(pro) may be a mechanism by which EV68 subverts host innate immune responses.
EV68 is a globally emerging pathogen, but the molecular basis of EV68 pathogenesis is unclear. Here we report that EV68 inhibits TLR3-mediated innate immune responses by targeting TRIF. Further investigations revealed that TRIF is cleaved by 3C(pro). These results suggest that control of TRIF by 3C(pro) may be a mechanism by which EV68 impairs type I IFN production in response to TLR3 activation.
人类肠道病毒 68(EV68)是 EV-D 种的一个成员,属于小核糖核酸病毒科肠道病毒属。在过去的几年中,越来越多的呼吸道疾病与 EV68 相关的爆发被记录下来。作为一种全球新兴病原体,EV68 感染成人和儿童。然而,EV68 发病机制的分子基础尚不清楚。在这里,我们报告 EV68 通过靶向 TIR 结构域包含衔接诱导β干扰素(TRIF)来抑制 Toll 样受体 3(TLR3)介导的先天免疫反应。在受感染的 HeLa 细胞中,EV68 抑制 poly(I·C)诱导的干扰素调节因子 3(IRF3)激活和β干扰素(IFN-β)表达。进一步的研究表明,TLR3 的关键衔接子 TRIF 是 EV68 的靶标。单独表达时,EV68 编码的蛋白酶 3C(pro) 切割 TRIF。3C(pro) 在 Q312 和 Q653 处介导 TRIF 的切割,这两个位点分别位于氨基末端和羧基末端结构域。这种切割依赖于 3C(pro) 的半胱氨酸蛋白酶活性。TRIF 的切割消除了 TRIF 激活 NF-κB 和 IFN-β 信号的能力。这些结果表明,3C(pro) 对 TRIF 的控制可能是 EV68 颠覆宿主先天免疫反应的一种机制。
EV68 是一种全球新兴的病原体,但 EV68 发病机制的分子基础尚不清楚。在这里,我们报告 EV68 通过靶向 TRIF 抑制 TLR3 介导的先天免疫反应。进一步的研究表明,TRIF 被 3C(pro) 切割。这些结果表明,3C(pro) 对 TRIF 的控制可能是 EV68 削弱 TLR3 激活后 I 型 IFN 产生的一种机制。